Last reviewed · How we verify
NCT07111156
A Clinical Study to Test the Safety and Effectiveness of Pinorox® for Improving Visible Signs of Facial Aging Such as Wrinkles, Fine Lines, and Dark Spots.
NA trial testing Topical Cream containing 0.1% Pinorox® in Fine Lines in 81 participants. Participants enrolled and being followed up; not accepting new ones.
17 February 2026
Quick facts
| Lead sponsor | NovoBliss Research Pvt Ltd |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 81 |
| Start date | 16 October 2025 |
| Primary completion | 17 February 2026 |
| Estimated completion | 17 February 2026 |
| Sites | 1 location across India |
Drugs / interventions tested
- Topical Cream containing 0.1% Pinorox®
- Topical Cream containing 1% Pinorox®
- Placebo (Base Cream)
Conditions studied
- Fine Lines — all drugs for Fine Lines →
- Wrinkles — all drugs for Wrinkles →
- Facial Sign of Aging — all drugs for Facial Sign of Aging →
Sponsor
NovoBliss Research Pvt Ltd — full company profile →
Who can join
Adults 35 to 55, any sex, with Fine Lines or Wrinkles. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A Randomized, Double-Blind, Three-Arm, Prospective, Single-Center Clinical Study to Evaluate the Safety, Efficacy, and Tolerability of Pinorox® in Subjects with Facial Signs of Aging
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07111156
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Fine Lines
Currently open trials in the same condition.
- NCT06869252 — Autologous Adipose Cells Therapy · Phase 1, PHASE2 · recruiting
- NCT04540900 — A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) fo · Phase 1 · active not recruiting
Other NovoBliss Research Pvt Ltd trials
Trials by the same sponsor.
- NCT07466667 — To Determine the Effect of Phaseolean on Glycemic Response to Carbohydrate Rich Meal in Healthy Adult Human Participants · NA · not yet recruiting
- NCT07423325 — Validation of Skin Instrumentation to Detect Ceramide-Driven Lipid Replenishment - Assessing Skin Glow, Hydration, Trans · NA · not yet recruiting
- NCT07333300 — Exploratory Clinical Investigation on Neurosensory Responses Via EEG Headband in Adults With Mild to Moderate Atopic Der · NA · not yet recruiting
- NCT07324759 — Clinical Study to Assess Safety, Effectiveness and In-Use Tolerability of Saffron Extract Capsules for Improving Skin He · NA · not yet recruiting
- NCT07195487 — A Clinical Study to Evaluate the Safety, Effectiveness and In-Use Tolerability of Hair Growth and Scalp Health Serum in · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07111156 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NovoBliss Research Pvt Ltd
- Last refreshed: 30 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07111156.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing